AbbVie (ABBV) insider buying
6 open-market purchases of ABBV by AbbVie's executives and directors since October 2025, worth $0 in total, from SEC Form 4 filings.
The most recent: Ro Khanna bought — on February 5, 2026.
The biggest buyer over the period is Ro Khanna: 4 purchases, $0.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 4 | $0 |
| 2025 | 2 | $0 |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Ro Khanna | 4 | $0 |
| Lisa C. Mcclain | 2 | $0 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Feb 5, 2026 | Ro Khanna |
0 | $218.44 | — | — |
| Feb 5, 2026 | Ro Khanna |
0 | $218.44 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $219.21 | — | — |
| Jan 23, 2026 | Ro Khanna |
0 | $219.21 | — | — |
| Oct 30, 2025 | Lisa C. Mcclain |
0 | $228.35 | — | — |
| Oct 30, 2025 | Lisa C. Mcclain |
0 | $228.35 | — | — |
Questions
Are AbbVie insiders buying the stock?
6 open-market purchases of ABBV by AbbVie's executives and directors since October 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on February 5, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From AbbVie's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.